Nephrogenic fibrosing dermopathy overview: Difference between revisions
Jump to navigation
Jump to search
(Created page with "__NOTOC__ {{Nephrogenic fibrosing dermopathy}} {{CMG}} ==Overview== ==Overview== '''Nephrogenic fibrosing dermopathy''' or '''nephrogenic systemic fibrosis''' is a rare and s...") |
No edit summary |
||
| (One intermediate revision by the same user not shown) | |||
| Line 1: | Line 1: | ||
__NOTOC__ | __NOTOC__ | ||
{{Nephrogenic | |||
{{Nephrogenic fribrosing dermopathy}} | |||
{{CMG}} | {{CMG}} | ||
Latest revision as of 14:44, 28 September 2012
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]
Overview
Overview
Nephrogenic fibrosing dermopathy or nephrogenic systemic fibrosis is a rare and serious syndrome that involves fibrosis of skin, joints, eyes, and internal organs. Its cause is not fully understood, but it seems to be associated with exposure to gadolinium (which is frequently used as a contrast substance for MRIs) in patients with severe kidney failure. It does not have a genetic basis.